levamisole has been researched along with transforming growth factor beta in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiba, H; Hirota, S; Iba, K; Ishii, S; Mori, M; Sawada, N | 1 |
| Aflatoonian, MR; Bamorovat, M; Fekri, A; Heshmatkhah, A; Keyhani, A; Khosravi, A; Mostafavi, M; Naderi, A; Oliaee, RT; Parizi, MH; Sharifi, I; Varma, RS | 1 |
2 other study(ies) available for levamisole and transforming growth factor beta
| Article | Year |
|---|---|
Glucocorticoids induce mineralization coupled with bone protein expression without influence on growth of a human osteoblastic cell line.
Topics: Alkaline Phosphatase; Calcification, Physiologic; Calcitriol; Cell Division; Cell Line; Cell Transformation, Viral; Dose-Response Relationship, Drug; Fibroblast Growth Factor 2; Gene Expression; Glucocorticoids; Humans; Interleukin-4; Levamisole; Microscopy, Electron; Minerals; Osteoblasts; Protein Biosynthesis; Proteins; Simian virus 40; Spectrum Analysis; Time Factors; Transforming Growth Factor beta; Tretinoin | 1995 |
A single-group trial of end-stage patients with anthroponotic cutaneous leishmaniasis: Levamisole in combination with Glucantime in field and laboratory models.
Topics: Adolescent; Adult; Aged; Animals; Antiprotozoal Agents; Cell Line; Cell Survival; Child; Chronic Disease; Drug Combinations; Drug Therapy, Combination; Female; Humans; Interleukin-10; Interleukin-12 Subunit p40; Leishmania tropica; Leishmaniasis, Cutaneous; Levamisole; Macrophages; Male; Meglumine Antimoniate; Mice; Middle Aged; Nitric Oxide Synthase Type II; Transforming Growth Factor beta; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult | 2019 |